Article

P53 is required for the developmental restriction in Müller glial proliferation in mouse retina

Department of Biological Structure, University of Washington, Seattle, Washington, USA.
Glia (Impact Factor: 5.47). 10/2012; 60(10):1579-89. DOI: 10.1002/glia.22377
Source: PubMed

ABSTRACT Müller glia are normally mitotically quiescent cells, but in certain pathological states they can re-enter the mitotic cell cycle. While several cell cycle regulators have been shown to be important in this process, a role for the tumor suppressor, p53, has not been demonstrated. Here, we investigated a role for p53 in limiting the ability of Müller glia to proliferate in the mature mouse retina. Our data demonstrate that Müller glia undergo a developmental restriction in their potential to proliferate. Retinal explants or dissociated cultures treated with EGF become mitotically quiescent by the end of the second postnatal week. In contrast, Müller glia from adult trp53-/+ or trp53-/- mice displayed a greater ability to proliferate in response to EGF stimulation in vitro. The enhanced proliferative ability of trp53 deficient mice correlates with a decreased expression of the mitotic inhibitor Cdkn1a/p21(cip) and an increase in c-myc, a transcription factor that promotes cell cycle progression. These data show that p53 plays an essential role in limiting the potential of Müller glia to re-enter the mitotic cycle as the retina matures during postnatal development.

0 Followers
 · 
220 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The primary glial cells in the retina, the Müller glia, differentiate from retinal progenitors in the first postnatal week. CNTF/LIF/STAT3 signaling has been shown to promote their differentiation; however, another key glial differentiation signal, BMP, has not been examined during this period of Müller glial differentiation. In the course of our analysis of the BMP signaling pathway, we observed a transient wave of Smad1/5/8 signaling in the inner nuclear layer at the end of the first postnatal week, from postnatal day (P) 5 to P9, after the end of neurogenesis. To determine the function of this transient wave, we blocked BMP signaling during this period in vitro or in vivo, using either a BMP receptor antagonist or noggin (Nog). Either treatment leads to a reduction in expression of the Müller glia-specific genes Rlbp1 and Glul, and the failure of many of the Müller glia to repress the bipolar/photoreceptor gene Otx2. These changes in normal Müller glial differentiation result in permanent disruption of the retina, including defects in the outer limiting membrane, rosette formation and a reduction in functional acuity. Our results thus show that Müller glia require a transient BMP signal at the end of neurogenesis to fully repress the neural gene expression program and to promote glial gene expression. © 2015. Published by The Company of Biologists Ltd.
    Development 02/2015; 142(3):533-43. DOI:10.1242/dev.118745 · 6.27 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: The in vitro expansion of multilineage competent primary neural progenitor cells is typically limited. Hedgehog (Hh) signalling is required in vivo for the maintenance of stem cell (SC) and progenitor populations in the central nervous system, including the retina. Here we investigated the impact of Hh signalling on in vitro expansion of perinatal mouse retinal progenitor cells (RPCs). Methods: Perinatal mouse retinal cells were treated with combinations of Hh-agonist, EGF/FGF2 and the cultures were assayed for long term growth, gene expression and dependence on Gli2. Differentiation was assessed in monolayer cultures, following in vivo transplantation and in cellular re-aggregates. Results: Using a combination of Hh agonist, EGF and FGF2 we were able to establish long term RPC cultures (termed Hh-RPCs). The ability of this combinatorial signaling approach to block quiescence of these Hh-RPCs was not associated with altered Tp53/Mdm2 levels or Hh-EGF cooperativity gene expression. Efficient Hh-RPC expansion and monolayer culture establishment requires Gli2, as Hh-RPCs derived from Gli2 knock-out retinal tissue fail to generate cultures that can be passaged long term in vitro. Hh-RPCs retain competence for neurogenic and gliogenic differentiation in vitro. However, they fail to engraft and differentiate into retinal cell types following in vivo transplantation to the eye or in vitro when, mixed with acutely dissociated perinatal retinal cells. Conclusions: Our data show that combining Hh and mitogen signaling is sufficient to promote the expansion of RPCs in vitro, but it is insufficient to maintain competence of these cells for retinal differentiation.
    Investigative ophthalmology & visual science 11/2013; 55(1). DOI:10.1167/iovs.13-12592 · 3.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Retinal Müller glia can serve as a source for regeneration of damaged retinal neurons in fish, birds and mammals. However, the proliferation rate of Müller glia has been reported to be low in the mammalian retina. To overcome this problem, growth factors and morphogens have been studied as potent promoters of Müller glial proliferation, but the molecular mechanisms that limit the proliferation of Müller glia in the mammalian retina remain unknown. In the present study, we found that the degree of damage-induced Müller glia proliferation varies across mouse strains. In mouse line 129×1/SvJ (129), there was a significantly larger proliferative response compared with that observed in C57BL/6 (B6) after photoreceptor cell death. Treatment with a Glycogen synthase kinase 3 (GSK3) inhibitor enhanced the proliferation of Müller glia in 129 but not in B6 mouse retinas. We therefore focused on the different gene expression patterns during retinal degeneration between B6 and 129. Expression levels of Cyclin D1 and Nestin correlated with the degree of Müller glial proliferation. A comparison of genome-wide gene expression between B6 and 129 showed that distinct sets of genes were upregulated in the retinas after damage, including immune response genes and chromatin remodeling factors.
    PLoS ONE 04/2014; 9(4):e94556. DOI:10.1371/journal.pone.0094556 · 3.53 Impact Factor